论文信息 - A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas - 字舞流文

A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas

Dong-Wan Kim | D. Heo | J. Lee | Y. Jeon | B. Keam | T. Kim | J. S. Lee | Jiwon Koh | Jeong-Ok Lee | Miso Kim | J. Lee